At the 2024 Precision Health Summit, Amrie Grammer, Founder, President, and Chief Scientific Officer of AMPEL Biosolutions, presents a vision of how precision medicine can reshape autoimmune and inflammatory disease treatment.

Dr. Grammer is a Biotech Executive and NIH-trained Scientist-Entrepreneur (Immunology, Genomics, Pharmacology, ML/PredictiveAI) who has successfully translated her discoveries into a precision health business with prognostic tests for patients and monitoring biomarkers for pharma. 

AMPEL’s ARPA-H spoke election highlights one-of-a-kind Precision Health tests that predict inflammation and abnormal drug targets from gene expression utilizing “explainable AI” (xAI).  Other corporate Hub Spoke members include Verily, Datavant, Velsara, QuidelOrtho and Biolabs. 

CBIC of Virginia honored the  team with “Innovator-of-the-Year” last night June 1st for the AMPEL Genomic Platform of RNA analytics and Machine Learning for dynamic disease management through flare prediction & personalized decision support for drug options. Charlottesville Business Innovation Council (CBIC) presented AMPEL’s “Innovator-of-the-Year” award at the University of Virginia Research Park.

Virginia officials recognized AMPEL BioSolutions for their dedication to identifying, training, and retaining STEM-trained workers, especially in the area of precision medicine. The annual award recognizes Virginia employers who provide high-quality internships to students.

Tune in to this exciting episode of BioTalk with Rich Bendis, featuring Dr. Amrie Grammer, Co-Founder of AMPEL BioSolutions. In this enlightening discussion, Dr. Grammer unveils the secrets behind AMPEL’s remarkable success in precision medicine, making this episode a must-listen.

The Virginia Catalyst, also known as the Virginia Biosciences Health Research Corporation (VBHRC), today announced that it has awarded $2 million in grants to four life and bioscience projects in the Commonwealth of Virginia, pending execution of the grant agreements.

“We could have formed this company anywhere, but we chose Charlottesville because of the great community that’s here,” says Dr. Amrie Grammer, co-founder, president and chief scientific officer of AMPEL BioSolutions.

Suzanne Youngkin shared the goals of the W+g initiative focused on wellbeing and workforce in Virginia during her March 30th visit to AMPEL BioSolutions, a women-owned business founded, headquartered and growing in Charlottesville.  The focus of AMPEL's business is...

The critical mass achieved by these collaborations provides Virginia with competitive advantages over other states and has resulted in significant outside capital being invested to finance the commercialization of Virginia’s innovations and create significant high-paying jobs for the Commonwealth.

AMPEL BioSolutions, LLC. is being recognized by Virginia officials for its internship program. It is the only tech company in Charlottesville recognized this cycle. AMPEL says its priority is contributing to knowledge of the future. Interns are able to examine RNA, work on projects, and provide design support for doctors